Cargando…

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma

Ferroptosis is a special form of regulatory cell death caused by the accumulation of intracellular iron and lipid peroxidation. Here, we summarize the research progress on ferroptosis in hepatocellular carcinoma (HCC), trace the development of the concept of ferroptosis and its key regulatory factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Hao, Shi, Juanyi, Wen, Kai, Lin, Jianhong, Liu, Qinghua, Shi, Bingchao, Yan, Yongcong, Xiao, Zhiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403010/ https://www.ncbi.nlm.nih.gov/pubmed/34466409 http://dx.doi.org/10.2147/JHC.S325593

Ejemplares similares

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis
por: Wen, Kai, et al.
Publicado: (2023)

Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma
por: Liu, Haohan, et al.
Publicado: (2020)

Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
por: Tao, Meng, et al.
Publicado: (2023)

Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis
por: Liu, Haohan, et al.
Publicado: (2022)

Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma
por: Yan, Yongcong, et al.
Publicado: (2019)

PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK
por: Zhou, Qiming, et al.
Publicado: (2020)

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019)

INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma
por: Zhou, Qianlei, et al.
Publicado: (2022)

Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression
por: Yan, Yongcong, et al.
Publicado: (2020)

The Critical Role of Ferroptosis in Hepatocellular Carcinoma
por: Pan, Fan, et al.
Publicado: (2022)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study
por: Xiao, Zhiyu, et al.
Publicado: (2019)

Identification of Ferroptosis‐related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy
por: Long, Shichao, et al.
Publicado: (2022)

New perspectives on ferroptosis and its role in hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer
por: Yan, Yongcong, et al.
Publicado: (2020)

The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods
por: Xiong, Yuanpeng, et al.
Publicado: (2022)

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study
por: Mao, Kai, et al.
Publicado: (2018)

Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
por: Ma, Shiwen, et al.
Publicado: (2022)

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma
por: Xu, Qiaodong, et al.
Publicado: (2018)

Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
por: Bai, Tao, et al.
Publicado: (2019)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma
por: Yang, Xin, et al.
Publicado: (2022)

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
por: Li, Yan, et al.
Publicado: (2023)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
por: Liu, Zhili, et al.
Publicado: (2023)

GLS2 shapes ferroptosis in hepatocellular carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2023)

The advanced development of molecular targeted therapy for hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2022)

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma
por: Meng, Jingshu, et al.
Publicado: (2023)

Retracted: Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

The ubiquitin‐specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression
por: Yan, Bokang, et al.
Publicado: (2023)

Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
por: He, Yongfei, et al.
Publicado: (2021)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Identify an innovative ferroptosis‐related gene in hepatocellular carcinoma
por: Hu, Gangfeng, et al.
Publicado: (2022)

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
por: Li, Xiaoju, et al.
Publicado: (2022)

Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma
por: Liu, Man-ru, et al.
Publicado: (2023)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3u42vtkpqg92d3rjqvr0ndb3pf